patent/NO-20062371-L

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20062371-L

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate	2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee5af904a74cab81a28de8fbe0c0e01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070c67d4d7c2c2bb2e6fa3e1436b2dab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc4f1ea78cef43ad8c67c5be47ec7878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9f44c75da584cda2145ec234477fc40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f70fb6a2c6ce48a86e1fd8c126b644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d992fc0ab927a357d7975c5ce236359 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7dbed7589c330d96fa960ca8a3b2b8a
publicationDate	2006-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	NO-20062371-L
titleOfInvention	Hitherto unknown crystalline forms of {2- [1- (3,5-bis-trifluoromethyl-benzyl) -5-pyridin-4-yl-1H- [1,2,3] triazol-4-yl] -pyridine 3-yl} - (2-chlorophenyl) -methanone
abstract	The present invention provides hitherto unknown crystalline forms of {2- [1- (3,5-bistrifluoromethylbenzyl) -5-pyridin-4-yl-1H- [1,2,3] triazol-4-yl] -pyridin-3- yl} - (2-chlorophenyl) -methanone, compositions thereof, intermediates thereof, methods of using the same, methods of using the same and methods of making intermediates thereof.
priorityDate	2003-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419676935 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9916461

Total number of triples: 31.